Stay updated with breaking news from Visionary Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regenerative medicine startup Pelage Pharmaceuticals has clinical data showing its small molecule activated hair follicle stem cells. GV led a Series A round that funded the UCLA spinout’s Phase 1 clinical trial and will also support Phase 2 testing this year.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on reshaping vision possibilities, today announced that the U.S....
SAN DIEGO — Surgeons should optimize their treatment of dysphotopsias based on each patient’s natural ability for neuroadaptation, according to a speaker here.
SAN DIEGO — A key to becoming an innovator in ophthalmology is to never let your patients feel abandoned, a speaker said here.